This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2004 Jun;3(6):479-87.

doi: 10.1038/nrd1415.

GSK3 inhibitors: development and therapeutic potential

Philip Cohen¹, Michel Goedert

Affiliations

PMID: 15173837
DOI: 10.1038/nrd1415

Review

GSK3 inhibitors: development and therapeutic potential

Philip Cohen et al. Nat Rev Drug Discov. 2004 Jun.

. 2004 Jun;3(6):479-87.

doi: 10.1038/nrd1415.

Authors

Philip Cohen¹, Michel Goedert

Affiliation

¹ MRC Protein Phosphorylation Unit, School of Life Sciences, University of Dundee, Dundee, DD1 5EH, UK. p.cohen@dundee.ac.uk

PMID: 15173837
DOI: 10.1038/nrd1415

No abstract available

PubMed Disclaimer

Similar articles

MEN-10755. Menarini.
Jones K. Jones K. Curr Opin Investig Drugs. 2003 Dec;4(12):1473-8. Curr Opin Investig Drugs. 2003. PMID: 14763135 Review.
CMT-3. CollaGenex.
Fingleton B. Fingleton B. Curr Opin Investig Drugs. 2003 Dec;4(12):1460-7. Curr Opin Investig Drugs. 2003. PMID: 14763133 Review.
Drug treatment for chronic obstructive pulmonary disease.
Wark P. Wark P. IDrugs. 2003 Sep;6(9):874-9. IDrugs. 2003. PMID: 12964067 Review.
Glycogen synthase kinase 3: a drug target for CNS therapies.
Bhat RV, Budd Haeberlein SL, Avila J. Bhat RV, et al. J Neurochem. 2004 Jun;89(6):1313-7. doi: 10.1111/j.1471-4159.2004.02422.x. J Neurochem. 2004. PMID: 15189333 Review.
[A new target for diabetes therapy: advances in the research of glycogen synthase kinase-3 inhibitors].
Liu SN, Shen ZF. Liu SN, et al. Yao Xue Xue Bao. 2007 Dec;42(12):1227-31. Yao Xue Xue Bao. 2007. PMID: 18338632 Review. Chinese.

See all similar articles

Cited by

Phosphorylation and SCF-mediated degradation regulate CREB-H transcription of metabolic targets.
Barbosa S, Carreira S, Bailey D, Abaitua F, O'Hare P. Barbosa S, et al. Mol Biol Cell. 2015 Aug 15;26(16):2939-54. doi: 10.1091/mbc.E15-04-0247. Epub 2015 Jun 24. Mol Biol Cell. 2015. PMID: 26108621 Free PMC article.
Anti-inflammatory activity of Wnt signaling in enteric nervous system: in vitro preliminary evidences in rat primary cultures.
Di Liddo R, Bertalot T, Schuster A, Schrenk S, Tasso A, Zanusso I, Conconi MT, Schäfer KH. Di Liddo R, et al. J Neuroinflammation. 2015 Feb 3;12:23. doi: 10.1186/s12974-015-0248-1. J Neuroinflammation. 2015. PMID: 25644719 Free PMC article.
Pharmacologically blocking p53-dependent apoptosis protects intestinal stem cells and mice from radiation.
Wang X, Wei L, Cramer JM, Leibowitz BJ, Judge C, Epperly M, Greenberger J, Wang F, Li L, Stelzner MG, Dunn JCY, Martin MG, Lagasse E, Zhang L, Yu J. Wang X, et al. Sci Rep. 2015 Apr 10;5:8566. doi: 10.1038/srep08566. Sci Rep. 2015. PMID: 25858503 Free PMC article.
CG0009, a novel glycogen synthase kinase 3 inhibitor, induces cell death through cyclin D1 depletion in breast cancer cells.
Kim HM, Kim CS, Lee JH, Jang SJ, Hwang JJ, Ro S, Choi J. Kim HM, et al. PLoS One. 2013;8(4):e60383. doi: 10.1371/journal.pone.0060383. Epub 2013 Apr 2. PLoS One. 2013. PMID: 23565238 Free PMC article.
GSK3beta regulates differentiation and growth arrest in glioblastoma.
Korur S, Huber RM, Sivasankaran B, Petrich M, Morin P Jr, Hemmings BA, Merlo A, Lino MM. Korur S, et al. PLoS One. 2009 Oct 13;4(10):e7443. doi: 10.1371/journal.pone.0007443. PLoS One. 2009. PMID: 19823589 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Other Literature Sources
- The Lens - Patent Citations Database